 Loughborough, England, Sept. 17, 2021 GLOBE NEWSWIRE -- Nemaura Medical, Inc. NASDAQ: NMRDNemaura or the Company, a medical technology company focused on developing and commercializing non-invasive wearable diagnostic devices and supporting personalized lifestyle coaching programs, announces that Dr. Osama Hamdy, MD, PhD, has joined their advisory board as consultant, and is expected to partake on and advise on Key Opinion leader studies in both the Diabetes field and Metabolic Health field using Nemauras glucose monitoring technology in the near future. 